Login
Toggle navigation
Videos
Categories
Trending
Sunil Grewal, Director of Gigabyte Technology India, discusses the partnership with Hospertz India Pvt Ltd.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Yeh Pei-Cheng. Chairman/President, Gigabyte Technology Co
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Investors Reveal How They Evaluate the Startup Landscape|Mike Edelhart,Managing Partner,Ataraxia VC
00:10:00
Greencoat UK Wind's Stephen Lilley discusses the company's robust full-year 2023 results, emphasizing substantial financial achievements and strategic milestones.
00:10:00
Accelerating Medical Innovation: Aislinn Capital's Role in Biotech Advancements
00:10:00
Charles Lehman on Urban Policy and the Jordan Neely Case|Charles Fain Lehman,Professor,Manhattan Institute
00:10:00
Exciting Gold Discoveries in Mali's Dan Doko Project
00:10:00
Expanding Horizons: A Deep Dive into the Growth and Strategy of a Major Food Service Operator in China
00:10:00
Finding Your Way Through Complex Waters | Michael Arougheti, CEO , Ares Management.
00:10:00
Crafting Your Financial Future | Smith Bruer Advisors
00:10:00
Tim Sime Discusses MFE Inspection Solutions' Innovations and Industry Trends
00:10:00
helping find smart capital for every stage of company|Greg Castle,Managing Partner,Anorak Ventures
00:10:00
Franco-Nevada Australia: Leading in Royalties and Streams
00:10:00
Inflation Indicators and Employment Trends: Key Takeaways and Upcoming Data | Rob McDougle, Vice-President, Zhang Financial.